Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Breast 2Sarcoma 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 967Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Leukemia, Lymphocytic, Chronic, B-Cell 555Leukemia 486Myelodysplastic Syndromes 375Lymphoma, Non-Hodgkin 347Lymphoma 297Lymphoma, Mantle-Cell 263Hematologic Neoplasms 260Lymphoma, Follicular 256Lymphoma, Large B-Cell, Diffuse 253Burkitt Lymphoma 232Lymphoma, B-Cell, Marginal Zone 227Recurrence 216Hodgkin Disease 182Multiple Myeloma 172Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 159Lymphoma, Large-Cell, Immunoblastic 158Leukemia, Myelomonocytic, Chronic 153Leukemia, Myelogenous, Chronic, BCR-ABL Positive 147Waldenstrom Macroglobulinemia 123Lymphoma, T-Cell, Cutaneous 116Neoplasms 112Lymphoma, Large-Cell, Anaplastic 111Blast Crisis 105Congenital Abnormalities 104Immunoblastic Lymphadenopathy 98Mycosis Fungoides 97Sezary Syndrome 96Myeloproliferative Disorders 92

Interventions

Standard of Care 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Cardiomyopathies × Other hematologic neoplasm × Clear all
NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

M.D. Anderson Cancer Center

Phase 1 Recruiting
72 enrolled
Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms

NCT02509156 2020-11-05

SENECA

The University of Texas Health Science Center, Houston

Phase 1 Completed
46 enrolled 46 charts
BreastLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Leukemia, Lymphoma, Cardiomyopathies, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡